JPWO2021010888A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021010888A5
JPWO2021010888A5 JP2022501270A JP2022501270A JPWO2021010888A5 JP WO2021010888 A5 JPWO2021010888 A5 JP WO2021010888A5 JP 2022501270 A JP2022501270 A JP 2022501270A JP 2022501270 A JP2022501270 A JP 2022501270A JP WO2021010888 A5 JPWO2021010888 A5 JP WO2021010888A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022501270A
Other versions
JP2022540859A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2020/050728 external-priority patent/WO2021010888A1/en
Publication of JP2022540859A publication Critical patent/JP2022540859A/ja
Publication of JPWO2021010888A5 publication Critical patent/JPWO2021010888A5/ja
Pending legal-status Critical Current

Links

JP2022501270A 2019-07-12 2020-07-10 新規bssl抗体 Pending JP2022540859A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1950888 2019-07-12
SE1950888-6 2019-07-12
PCT/SE2020/050728 WO2021010888A1 (en) 2019-07-12 2020-07-10 Novel bssl antibodies

Publications (2)

Publication Number Publication Date
JP2022540859A JP2022540859A (ja) 2022-09-20
JPWO2021010888A5 true JPWO2021010888A5 (ja) 2022-12-27

Family

ID=74210559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022501270A Pending JP2022540859A (ja) 2019-07-12 2020-07-10 新規bssl抗体

Country Status (11)

Country Link
US (1) US20220267469A1 (ja)
EP (1) EP3999115A4 (ja)
JP (1) JP2022540859A (ja)
KR (1) KR20220034775A (ja)
CN (1) CN114096275A (ja)
AU (1) AU2020315684A1 (ja)
BR (1) BR112022000391A2 (ja)
CA (1) CA3146193A1 (ja)
IL (1) IL289639A (ja)
MX (1) MX2022000484A (ja)
WO (1) WO2021010888A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023060137A2 (en) * 2021-10-05 2023-04-13 Board Of Regents, The University Of Texas System Methods and compositions comprising b7-h3 binding polypeptides
WO2024080920A1 (en) 2022-10-14 2024-04-18 Lipum Ab Anti-bssl antibodies for the treatment of cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501939D0 (sv) * 1995-05-24 1995-05-24 Astra Ab DNA molecules for expression of polypeptides
US7557193B2 (en) * 2004-03-31 2009-07-07 Universite De La Mediterranee Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics
EP1840573A1 (en) * 2006-03-27 2007-10-03 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
AU2008258503A1 (en) * 2007-06-08 2008-12-11 Inserm (Institut National De La Sante Et De La Recherche Medicale) Compositions and methods for treating pancreatic tumors
EP3831407A1 (en) * 2009-04-08 2021-06-09 LipUm AB New methods for treatment of inflammatory diseases
CN103476795B (zh) * 2011-03-29 2016-07-06 罗切格利卡特公司 抗体Fc变体
UA118028C2 (uk) * 2013-04-03 2018-11-12 Рош Глікарт Аг Біспецифічне антитіло, специфічне щодо fap і dr5, антитіло, специфічне щодо dr5, і спосіб їх застосування
CA2929256C (en) * 2013-11-04 2022-04-26 Glenmark Pharmaceuticals S.A. Production of t cell retargeting hetero-dimeric immunoglobulins

Similar Documents

Publication Publication Date Title
BR102023010976A2 (ja)
BR102023009641A2 (ja)
BR102023008688A2 (ja)
BR102023007252A2 (ja)
BR102022023461A2 (ja)
BR102022017795A2 (ja)
BR202022000931U2 (ja)
JPWO2021010888A5 (ja)
BY13162U (ja)
BY13157U (ja)
CN307046916S (ja)
CN307045749S (ja)
CN307045733S (ja)
CN307044909S (ja)
CN307047772S (ja)
BY13172U (ja)
BY13168U (ja)
BY13167U (ja)
BY13166U (ja)
BY13165U (ja)
CN307047979S (ja)
BY13163U (ja)
CN307048364S (ja)
CN307050852S (ja)
BY13161U (ja)